351,21
Section
21. 961.14 (4) (ww) of the statutes is created to read:
961.14 (4) (ww) 5-(2-aminopropyl)benzofuran, commonly known as 5-APB.
351,22
Section
22. 961.14 (4) (wx) of the statutes is created to read:
961.14 (4) (wx) 6-(2-aminopropyl)benzofuran, commonly known as 6-APB.
351,23
Section
23. 961.14 (4) (wy) of the statutes is created to read:
961.14 (4) (wy) 5-(2-aminopropyl)-2,3-dihydrobenzofuran, commonly known as 5-APDB.
351,24
Section
24. 961.14 (4) (wz) of the statutes is created to read:
961.14 (4) (wz) 6-(2-aminopropyl)-2,3-dihydrobenzofuran, commonly known as 6-APDB.
351,25
Section
25. 961.14 (4) (xa) of the statutes is created to read:
961.14 (4) (xa) 5-iodo-2-aminoindane, commonly known as 5-IAI.
351,26
Section
26. 961.14 (4) (xb) of the statutes is created to read:
961.14 (4) (xb) 4-methoxymethamphetamine, commonly known as PMMA.
351,27
Section
27. 961.14 (7) (intro.) of the statutes is amended to read:
961.14 (7) Stimulants. (intro.) Any material, compound, mixture or preparation which contains any quantity of any of the following substances having a stimulant effect on the central nervous system, including any of their precursors, analogs, salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
351,28
Section
28. 961.14 (7) (L) of the statutes is repealed and recreated to read:
961.14 (7) (L) Substituted cathinones. Any compound, except bupropion or compounds scheduled elsewhere in this chapter, that is structurally derived from 2-amino-propan-1-one by substitution at the 1-position with either phenyl, napthyl, or thiophene ring systems, whether or not the compound is further modified in any of the following ways: by substitution in the ring system to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl, hydroxyl, or halide substituents, whether or not further substituted in the ring system by one or more other univalent substituents; by substitution at the 3-position with an acyclic alkyl substituent; by substitution at the 2-amino nitrogen atom with alkyl, dialkyl, benzyl, or methoxybenzyl groups; by inclusion of the 2-amino nitrogen atom in a cyclic structure; or by any combination of these modifications. Substances specified under this subdivision include:
1. Methcathinone.
2. Methylenedioxypyrovalerone, commonly known as MDPV.
3. 4-methylmethcathinone, commonly known as mephedrone or 4-MMC.
4. 4-methylethcathinone, commonly known as 4-MEC.
5. 4-methoxy-alpha-pyrrolidinopropiophenone, commonly known as MOPPP.
6. 3,4-methylenedioxy-alpha-pyrrolidinopropiophenone, commonly known as MDPPP.
7. Alpha-pyrrolidinovalerophenone, commonly known as alpha-PVP.
8. 2-fluoromethcathinone, commonly known as 2-FMC.
9. 3-fluoromethcathinone, commonly known as 3-FMC.
10. 4-fluoromethcathinone, commonly known as 4-FMC or flephedrone.
11. 3,4-methylenedioxymethcathinone, commonly known as methylone or bk-MDMA.
12. Naphthylpyrovalerone, commonly known as naphyrone.
13. 4-methyl-alpha-pyrrolidinobutiophenone, commonly known as MPBP.
14. 4-methoxymethcathinone, commonly known as methedrone or bk-PMMA.
15. Ethcathinone.
16. 3,4-methylenedioxyethcathinone, commonly known as ethylone or bk-MDEA.
17. beta-Keto-N-methylbenzodioxolylbutanamine, commonly known as butylone or bk-MBDB.
18. N,N-dimethylcathinone, commonly known as metamfepramone.
19. Alpha-pyrrolidinopropiophenone, commonly known as alpha-PPP.
20. 3-methoxymethcathinone, commonly known as 3-MMC.
21. 4-ethylmethcathinone, commonly known as 4-EMC.
22. 3,4-dimethylmethcathinone, commonly known as 3,4-DMMC.
23. beta-Keto-N-methylbenzodioxolylpentanamine, commonly known as pentylone or bk-MBDP.
24. beta-Keto-ethylbenzodioxolylbutanamine, commonly known as eutylone or bk-EBDB.
25. 4-bromomethcathinone, commonly known as 4-BMC.
26. Alpha-methylamino-butyrophenone, commonly known as buphedrone or MABP.
27. 3,4-methylenedioxy-alpha-pyrrolidinobutiophenone, commonly known as MDPBP.
28. 4-methyl-alpha-pyrrolidinohexiophenone, commonly known as MPHP.
29. N,N-dimethyl-3,4-methylenedioxycathinone.
30. N,N-diethyl-3,4-methylenedioxycathinone.
31. Alpha-methylamino-valerophenone, commonly known as pentedrone.
351,29
Section
29. 961.14 (7) (m) and (n) of the statutes are repealed.
351,30
Section
30. 961.14 (7) (mk) of the statutes is created to read:
961.14 (7) (mk) Mitragynine.
351,31
Section
31. 961.14 (7) (mL) of the statutes is created to read:
961.14 (7) (mL) 7-hydroxymitragynine.
351,32
Section
32. 961.14 (7) (mm) of the statutes is created to read:
961.14 (7) (mm) 5,6-methylenedioxy-2-aminoindane, commonly known as MDAI.
351,33
Section
33. 961.14 (7) (mn) of the statutes is created to read:
961.14 (7) (mn) Benzothiophenylcyclohexylpiperidine, commonly known as BTCP.
351,34
Section
34. 961.16 (3) (tb) of the statutes is created to read:
961.16 (3) (tb) Oripavine.
351,35
Section
35. 961.16 (3) (zt) of the statutes is created to read:
961.16 (3) (zt) Tapentadol.
351,36
Section
36. 961.16 (8) (b) of the statutes is created to read:
961.16 (8) (b) An immediate precursor to fentanyl, including 4-anilino-N-phenethyl-4-piperidine, commonly known as ANPP.
351,37
Section
37. 961.18 (7) (am) of the statutes is created to read:
961.18 (7) (am) 19-Nor-4,9(10)-androstadienedione;
351,38
Section
38. 961.18 (7) (az) of the statutes is created to read:
961.18 (7) (az) Boldione;
351,39
Section
39. 961.18 (7) (em) of the statutes is created to read:
961.18 (7) (em) Desoxymethyltestosterone;
351,40
Section
40. 961.20 (2) (ax) of the statutes is created to read:
961.20 (2) (ax) Carisoprodol;
351,41
Section
41. 961.20 (2) (q) of the statutes is created to read:
961.20 (2) (q) Zopiclone.
351,42
Section
42. 961.20 (4) (d) of the statutes is created to read:
961.20 (4) (d) Lorcaserin, including any of its isomers and salts of isomers.
351,43
Section
43. 961.22 (4) of the statutes is created to read:
961.22 (4) Ezogabine. Ezogabine or any of its salts, isomers, or salts of isomers.
351,44
Section
44. 961.22 (5) of the statutes is created to read:
961.22 (5) Pregabalin. Pregabalin or any of its salts, isomers, or salts of isomers.
351,45
Section
45. 961.41 (1) (e) (intro.) of the statutes is amended to read:
961.41 (1) (e) Phencyclidine, amphetamine, methamphetamine, methcathinone, cathinone,
methylenedioxypyrovalerone, and 4-methylmethcathinone, N-benzylpiperazine, and a substance specified in s. 961.14 (7) (L). (intro.) If the person violates this subsection with respect to phencyclidine, amphetamine, methamphetamine, methcathinone, cathinone, methylenedioxypyrovalerone, or 4-methylmethcathinone, N-benzylpiperazine, a substance specified in s. 961.14 (7) (L), or a controlled substance analog of phencyclidine, amphetamine, methamphetamine, methcathinone, cathinone, methylenedioxypyrovalerone, or 4-methylmethcathinone, N-benzylpiperazine, or a substance specified in s. 961.14 (7) (L), and the amount manufactured, distributed, or delivered is:
351,46
Section
46. 961.41 (1) (em) of the statutes is created to read:
961.41 (1) (em) Synthetic cannabinoids. If a person violates this subsection with respect to a controlled substance specified in s. 961.14 (4) (tb), or a controlled substance analog of a controlled substance specified in s. 961.14 (4) (tb), and the amount manufactured, distributed, or delivered is:
1. Two hundred grams or less, the person is guilty of a Class I felony.
2. More than 200 grams but not more than 1,000 grams, the person is guilty of a Class H felony.
3. More than 1,000 grams but not more than 2,500 grams, the person is guilty of a Class G felony.
4. More than 2,500 grams but not more than 10,000 grams, the person is guilty of a Class F felony.
5. More than 10,000 grams, the person is guilty of a Class E felony.
351,47
Section
47. 961.41 (1) (hm) (intro.) of the statutes is amended to read:
961.41 (1) (hm) Certain other schedule I controlled substances and ketamine. (intro.) If the person violates this subsection with respect to gamma-hydroxybutyric acid, gamma-butyrolactone, 1,4-butanediol, 3,4-methylenedioxymethamphetamine, 4-bromo-2,5-dimethoxy-beta-phenylethylamine, 4-methylthioamphetamine, ketamine, a substance specified in s. 961.14 (4) (a) to (h), (m) to (q), (sm), or (u) to (xb), or a controlled substance analog of gamma-hydroxybutyric acid, gamma-butyrolactone, 1,4-butanediol, 3,4-methylenedioxymethamphetamine, 4-bromo-2,5-dimethoxy-beta-phenylethylamine, or 4-methylthioamphetamine, ketamine, or a substance specified in s. 961.14 (4) (a) to (h), (m) to (q), (sm), or (u) to (xb), and the amount manufactured, distributed, or delivered is:
